Fri, Sep 19, 2014, 7:42 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • doodootoyou doodootoyou Feb 1, 2013 10:23 AM Flag

    From Dec 19th SEC filing, exhibit 10A

    The compensation milestones are hidden at the very end of the filing.
    Note the requirement of the stock price and the date by which this is to occur. It is number (4)

    Management milestones that affect cash bonuses


    1)

    Successful administration of any Ampion TM , Optina TM and Zertane TM clinical trials financed by the company. Successful shall mean that the trial was performed on time and on budget and with a demonstration of efficacy that is statistically significant and the drug is cleared for commercialization by the regulatory authorities in all countries in which commercialization is planned.


    2) Obtain, on terms favorable to the company, license agreement, partnerships or other collaborations for the commercialization of the company’s drug portfolio


    3) Obtain insurance reimbursement codes for each drug that receives regulatory clearance to commercialize


    4) Within 6 months of the date of this agreement, obtain $15 million in equity financing for the company at a share price in excess of $5/share

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I can't find anything regarding a new CFO. They hired Disbrow as COO. Where can I find something about them replacing Mark McGregor as CFO? Was this just a typo and you meant COO?

      • 1 Reply to th3k33p3r24
      • yes, I meant Disbrow.
        Please read the post SEC filing Dec 19th. I posted it in case you can't find it this morning-- it's an attachment AMPIO made to the filing. It's long and at the very end it shows Disbrow's milestones he must reach in order to vest his options.
        It is both good and bad. Good in that it shows that the company plans to get the stock to $5 within 6 months of the filing of the Dec 19th form. Bad in the sense it will be further dilution of shares. And that is not to mention the unstated intentions of management to sell their shares.
        I have no idea of Disbrow's connections with mutual funds/retirement funds managers to get this much money. No connections with ivy league graduates, but with someone(s) since he's done this with the previous company he has worked for.

 
AMPE
3.48+0.04(+1.16%)Sep 19 4:03 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.